BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9804	Companies
196632	Keywords
127649	Articles
104544	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 10/10/2025 at 01:55, 3 months 25 days ago

BioNxt Solutions aborde le vote de l'assemblée générale annuelle en pleine grève postale

Assemblée Générale Annuelle Vote Campagne De Marketing Grève De Postes Canada Soumission Par Procuration
BRIEF

published on 10/10/2025 at 01:55, 3 months 25 days ago

BioNxt Solutions Addresses AGM Voting Amid Postal Strike

AGM Voting Marketing Campaign Canada Post Strike Proxy Submission
PRESS RELEASE

published on 10/10/2025 at 01:50, 3 months 25 days ago

BioNxt Solutions Provides Update To Annual General Meeting Matters Due To Canadian Postal Strike And IR Activities
BioNxt Solutions Inc. provides alternative voting options for shareholders due to Canada Post mail strike. Annual general meeting details and proxy voting instructions shared

Annual General Meeting Shareholders BioNxt Solutions Inc. Proxy Voting Voting Options
BRIEF

published on 10/09/2025 at 09:10, 3 months 26 days ago

BioNxt Completes Fast-Track Patent Filing for MS Treatment

Multiple Sclerosis Cladribine Patent Filing BioNxt Solutions Sublingual Delivery
BRIEF

published on 10/09/2025 at 09:10, 3 months 26 days ago

BioNxt finalise le dépôt accéléré d'un brevet pour le traitement de la sclérose en plaques

Sclérose En Plaques Cladribine Dépôt De Brevet Solutions BioNxt Administration Sublinguale
PRESS RELEASE

published on 10/09/2025 at 09:05, 3 months 26 days ago

BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis
BioNxt Solutions Inc. completes Track One priority patent filing with USPTO for sublingual thin-film cladribine formulation (BNT23001) targeting MS & other autoimmune diseases. Strategic move to strengthen IP position & advance regulatory approvals

BioNxt Solutions Inc. Multiple Sclerosis Patent Filing Sublingual Thin-Film Cladribine Formulation
BRIEF

published on 10/02/2025 at 09:10, 4 months 2 days ago

BioNxt Advances Targeted Chemotherapy Drug Delivery Platform

Biopharmaceutical Drug Delivery Research Advancements BioNxt Solutions Targeted Chemotherapy
BRIEF

published on 10/02/2025 at 09:10, 4 months 2 days ago

BioNxt développe une plateforme d'administration ciblée de médicaments de chimiothérapie

Biopharmaceutique Solutions BioNxt Administration De Médicaments Chimiothérapie Ciblée Avancées De La Recherche
PRESS RELEASE

published on 10/02/2025 at 09:05, 4 months 2 days ago

BioNxt Reports Update on Targeted Chemotherapy Drug Delivery Platform
BioNxt Solutions Inc. reports significant advancement in targeted chemotherapy delivery platform and upcoming definitive agreement. Proprietary technology aims at 10-fold increase in therapeutic effect while safeguarding healthy cells

BioNxt Solutions Inc. Oncology Treatments Chemotherapy Delivery Platform Targeted Drug Delivery System Therapeutic Effect
BRIEF

published on 09/29/2025 at 09:10, 4 months 5 days ago

BioNxt fait progresser le développement d'un médicament sublingual à base de cladribine pour le traitement de la sclérose en plaques

Sclérose En Plaques Cladribine Développement De Médicaments Biodisponibilité Sublingual

Accesswire

Published on 02/04/2026 at 18:00, 4 hours 3 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 5 hours 48 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 6 hours 18 minutes ago

Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 7 hours 3 minutes ago

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 14:30, 7 hours 33 minutes ago

Datametrex Expands Business In Data Centres

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 20:54, 1 hour 9 minutes ago

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 1 hour 27 minutes ago

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 2 hours 3 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 3 hours 8 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 3 hours 23 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology

Les Echos

Published on 02/04/2026 at 18:04, 3 hours 59 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 3 hours 59 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 4 hours 18 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 4 hours 18 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 4 hours 18 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE